In a recent evaluation of Hamlet Pharma, the European Commission concluded that Hamlet Pharma’s bladder cancer project has delivered exceptional results with immediate or potential…
Read More
Financial news
The shareholders of Hamlet Pharma AB (publ) (“Hamlet Pharma” or the “Company”), reg. no. 556568-8958, are hereby invited to the extraordinary general meeting on Wednesday,…
Aktieägarna i Hamlet Pharma AB (publ) (”Hamlet Pharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma onsdagen den 17 maj 2023 kl. 14:00 i…